NKTX
Price
$1.93
Change
-$0.12 (-5.85%)
Updated
Feb 24, 11:43 AM (EDT)
Capitalization
144.67M
24 days until earnings call
RLAY
Price
$3.75
Change
-$0.18 (-4.59%)
Updated
Feb 24, 11:50 AM (EDT)
Capitalization
656.14M
2 days until earnings call
Ad is loading...

NKTX vs RLAY

Header iconNKTX vs RLAY Comparison
Open Charts NKTX vs RLAYBanner chart's image
Nkarta
Price$1.93
Change-$0.12 (-5.85%)
Volume$652
Capitalization144.67M
Relay Therapeutics
Price$3.75
Change-$0.18 (-4.59%)
Volume$2.99K
Capitalization656.14M
NKTX vs RLAY Comparison Chart
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. RLAY commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Hold and RLAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (NKTX: $2.05 vs. RLAY: $3.92)
Brand notoriety: NKTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 168% vs. RLAY: 65%
Market capitalization -- NKTX: $144.67M vs. RLAY: $656.14M
NKTX [@Biotechnology] is valued at $144.67M. RLAY’s [@Biotechnology] market capitalization is $656.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 2 TA indicator(s) are bullish while RLAY’s TA Score has 3 bullish TA indicator(s).

  • NKTX’s TA Score: 2 bullish, 4 bearish.
  • RLAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both NKTX and RLAY are a bad buy in the short-term.

Price Growth

NKTX (@Biotechnology) experienced а -7.24% price change this week, while RLAY (@Biotechnology) price change was -2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.56%. For the same industry, the average monthly price growth was -4.45%, and the average quarterly price growth was +1.96%.

Reported Earning Dates

NKTX is expected to report earnings on May 08, 2025.

RLAY is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($656M) has a higher market cap than NKTX($145M). RLAY YTD gains are higher at: -4.854 vs. NKTX (-17.671). NKTX has higher annual earnings (EBITDA): -119.34M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. NKTX (283M). RLAY has less debt than NKTX: RLAY (49.8M) vs NKTX (85.4M). RLAY has higher revenues than NKTX: RLAY (10M) vs NKTX (0).
NKTXRLAYNKTX / RLAY
Capitalization145M656M22%
EBITDA-119.34M-389.45M31%
Gain YTD-17.671-4.854364%
P/E RatioN/AN/A-
Revenue010M-
Total Cash283M840M34%
Total Debt85.4M49.8M171%
TECHNICAL ANALYSIS
Technical Analysis
NKTXRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96273.920000-303.835940
-0.31%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-4.65%
FATE - NKTX
54%
Loosely correlated
-8.09%
IPSC - NKTX
49%
Loosely correlated
-2.51%
ALLO - NKTX
47%
Loosely correlated
-3.77%
PRME - NKTX
46%
Loosely correlated
-5.27%
ABCL - NKTX
45%
Loosely correlated
-3.50%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-4.16%
XNCR - RLAY
49%
Loosely correlated
-0.32%
RXRX - RLAY
42%
Loosely correlated
-10.34%
NKTX - RLAY
39%
Loosely correlated
-4.65%
TVTX - RLAY
38%
Loosely correlated
-6.79%
PRME - RLAY
38%
Loosely correlated
-5.27%
More